| 000 | 01803 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517223652.0 | ||
| 264 | 0 | _c20191016 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-018-27834-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartinez, Natalia J | |
| 245 | 0 | 0 |
_aA widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. _h[electronic resource] |
| 260 |
_bScientific reports _c06 2018 |
||
| 300 |
_a9472 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 9 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aEnzyme Stability |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHigh-Throughput Screening Assays _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLuciferases _xmetabolism |
| 650 | 0 | 4 |
_aNanotechnology _xmethods |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
| 700 | 1 | _aAsawa, Rosita R | |
| 700 | 1 | _aCyr, Matthew G | |
| 700 | 1 | _aZakharov, Alexey | |
| 700 | 1 | _aUrban, Daniel J | |
| 700 | 1 | _aRoth, Jacob S | |
| 700 | 1 | _aWallgren, Eric | |
| 700 | 1 | _aKlumpp-Thomas, Carleen | |
| 700 | 1 | _aCoussens, Nathan P | |
| 700 | 1 | _aRai, Ganesha | |
| 700 | 1 | _aYang, Shyh-Ming | |
| 700 | 1 | _aHall, Matthew D | |
| 700 | 1 | _aMarugan, Juan J | |
| 700 | 1 | _aSimeonov, Anton | |
| 700 | 1 | _aHenderson, Mark J | |
| 773 | 0 |
_tScientific reports _gvol. 8 _gno. 1 _gp. 9472 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-018-27834-y _zAvailable from publisher's website |
| 999 |
_c28557384 _d28557384 |
||